WIC
TRIB

Woodmont Investment Counsel’s Trinity Biotech TRIB Stock Holding History

Woodmont Investment Counsel’s Portfolio TRIB Stock Details TRIB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q4 		– Sell
-536
Closed -$1.06M – 577
2016
Q3 		$1.06M Sell
536
-8
-1% -$14.9K 0.3% 92
2016
Q2 		$925K Sell
544
-39
-7% -$65.9K 0.28% 97
2016
Q1 		$1.02M Buy
583
+81
+16% +$129K 0.31% 84
2015
Q4 		$885K Buy
502
+90
+22% +$159K 0.26% 101
2015
Q3 		$707K Hold
412
– – 0.22% 109
2015
Q2 		$1.12M Hold
412
– – 0.32% 86
2015
Q1 		$1.19M Sell
412
-58
-12% -$161K 0.37% 80
2014
Q4 		$1.24M Buy
470
+91
+24% +$235K 0.38% 77
2014
Q3 		$1.04M Buy
379
+41
+12% +$133K 0.3% 100
2014
Q2 		$1.17M Hold
338
– – 0.33% 94
2014
Q1 		$1.23M Sell
338
-103
-23% -$405K 0.36% 89
2013
Q4 		$1.67M Sell
441
-70
-14% -$252K 0.5% 63
2013
Q3 		$1.67M Sell
511
-67
-12% -$196K 0.61% 55
2013
Q2 		$1.46M Buy
+578
New +$1.44M 0.49% 67

Other funds holding TRIB

PIM
Paradice Investment Management Denver, Colorado $532M AUM 29.6% 1-Year Est. Return
HA
Heartland Advisors Milwaukee, Wisconsin $1.96B AUM 28.26% 1-Year Est. Return
Boston Partners
Boston Partners Boston, Massachusetts $95.5B AUM 28.4% 1-Year Est. Return
JHIU
Janus Henderson Investors US Denver, Colorado $122B AUM 18.26% 1-Year Est. Return
LAM
Lapides Asset Management Greenwich, Connecticut $153M AUM 9.03% 1-Year Est. Return
FWSM
First Wilshire Securities Management Pasadena, California $444M AUM 42.88% 1-Year Est. Return
SCM
Stonehill Capital Management New York $197M AUM 96.45% 1-Year Est. Return
2L
22NW LP Seattle, Washington $146M AUM 29.83% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
SM
Senvest Management New York $3.01B AUM 35.7% 1-Year Est. Return

Woodmont Investment Counsel's TRIB Position: Q4 2016 in Review

Woodmont Investment Counsel sold out of Trinity Biotech (TRIB) in Q4 2016, closing a stake of 536 shares — an estimated $1.06M sold.

Woodmont Investment Counsel first reported a position in TRIB in Q2 2013 and held it in 14 quarters. The position peaked at $1.67M in Q3 2013. 71 funds tracked by Wall St. Rank hold TRIB as of Q4 2016.

  • Woodmont Investment Counsel reported no remaining Trinity Biotech position as of Q4 2016 after selling out during the quarter.
  • Woodmont Investment Counsel sold 536 Trinity Biotech shares in Q4 2016, an estimated $1.06M.
  • Woodmont Investment Counsel first reported a position in Trinity Biotech in Q2 2013 and held it in 14 quarters.
  • Woodmont Investment Counsel's Trinity Biotech position peaked at $1.67M in Q3 2013.
  • 71 funds tracked by Wall St. Rank held Trinity Biotech as of Q4 2016.

Based on Woodmont Investment Counsel's 13F filing for Q4 2016, filed 13 Feb 2017.